Supported by

Tricuspid / Pulmonary valve

Latest tricuspid content in interventional cardiology - research, practice, and education

Endovascular treatments for complications of the tricuspid or pulmonary valve, such as the treatment for tricuspid regurgitation (TR), are at an early stage of clinical development with many novel devices being introduced each year. This topic explores the different parameters of this emerging field with information on the latest research, emerging tools, devices and techniques, vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography as well as understanding bleeding risks or patient selection. Find out more…

Filtered By
Tricuspid / Pulmonary valve

523 results

Mitral and tricuspid patients are different from the TAVI population - Impact on clinical care

28 Nov 2022 – From PCR London Valves 2022

Consult this session to learn more about the different needs of mitral and tricuspid patients, to appreciate what optimal medical therapy really means and to improve your knowledge of the anticoagulant requirements for different patient populations.

Mitral and tricuspid patients are different from the TAVI population - Impact on clinical care

Transcatheter primary mitral regurgitation repair and tricuspid replacement - LIVE case

28 Nov 2022 – From PCR London Valves 2022

  • Part 1: Primary MR repair (recorded case)
    An 89-year-old male with atrial fibrillation, severe primary MR (prolapse A1-A2) with a preserved LV function. The operators implant 1 Pascal ACE, on general anaesthesia, guided by TEE.
  • Part 2: Tricuspid valve in valve (Live case)
    A 52-year-old female, with diabetes and...
Transcatheter intervention for mitral and tricuspid valve disease: state of the art

Patient selection for tricuspid valve interventions

28 Nov 2022 – From PCR London Valves 2022

Consult this session to learn more about the anatomical assessment of candidates for transcatheter tricuspid valve interventions, to understand the importance of detailed haemodynamic assessment in patients with severe tricuspid regurgitation and to discuss the predictors of clinical outcome after these interventions.

Patient selection for tricuspid valve interventions

Combined valve interventions

28 Nov 2022 – From PCR London Valves 2022

Among the very interesting cases presented in this PCR LV 2022 session, watch the 1st case of TMVR and TTVR in a patient with the use of dedicated investigational devices, simultaneous transcatheter mitral and tricuspid approach in a patient with dextrocardia, or simultaneous mitral valve-in-valve, tricuspid...

Combined valve interventions

Learning transcatheter tricuspid valve interventions: the essentials

28 Nov 2022 – From PCR London Valves 2022

Take a look at these presentations to learn more about the anatomical information required to perform transcatheter tricuspid valve procedures safely and effectively, the essentials of echocardiographic imaging for patient selection and peri-procedural guidance, as well as the most commonly used devices for tricuspid interventions.

Learning transcatheter tricuspid valve interventions: the essentials

The right valves for the right ventricle: Venus MedTech tricuspid and pulmonary replacement systems

27 Nov 2022 – From PCR London Valves 2022

In this session from PCR London Valves 2022, discover the new Venus MedTech technology for tricuspid and pulmonary valve replacement, and a review of the clinical indications, selection criteria and procedural details.

The right valves for the right ventricle: Venus MedTech tricuspid and pulmonary replacement systems

Therapy of valvular heart diseases: a patient-centred innovation journey

27 Nov 2022 – From PCR London Valves 2022

Join a team of experts as they review together the complete spectrum of valvular heart disease and ways in which we can manage it using emerging novel technologies.

Therapy of valvular heart

Rapid-fire abstracts: session 1

27 Nov 2022 – From PCR London Valves 2022

Watch this PCR LV 2022 session to get clinical outcomes after TAVR in obese and non-obese patients with small aortic annuli, to find out how non-calcific aortic valve tissue quantified from coronary CT angiography can predict one-year mortality post-TAVI, and even more!

Rapid-fire abstracts: session 1

Rapid-fire clinical cases: Session 1

27 Nov 2022 – From PCR London Valves 2022

Discover a selection of PCR London Valves 2022 case submissions in this session: quadricuspid aortic valve with pure regurgitation treated with Evolut PRO, complex high-risk patient with severe aortic regurgitation and extra-large anatomy, snare-assisted TAVI in case of calcified sinotubular junction, and more!

Rapid-fire clinical cases: Session 1

Imaging for tricuspid valve interventions: anatomical assessment, grading of severity and peri-procedural guidance

27 Nov 2022 – From PCR London Valves 2022

Consult these presentations on imaging for tricuspid valve interventions to learn more about how to adequately assess tricuspid valve anatomy and identify which criteria determine procedure-related prognosis, how to determine the severity of tricuspid regurgitation and identify key pitfalls in assessment, as well as how to guide a...

Imaging for tricuspid valve interventions: anatomical assessment, grading of severity and peri-procedural guidance